SSRIs And Suicide To Be Discussed By Pediatric Advisory Cmte. In September
Executive Summary
FDA's Pediatric Advisory Committee will hold its first meeting in September as a joint session with the Psychopharmacologic Advisory Committee
You may also be interested in...
Duragesic “Black Box” Should Include Pediatric Death Warning – Cmte.
Enhanced Duragesic "black box" warnings on pediatric deaths are recommended by FDA's Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee
Duragesic “Black Box” Should Include Pediatric Death Warning – Cmte.
Enhanced Duragesic "black box" warnings on pediatric deaths are recommended by FDA's Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee
Antidepressant Warnings On Pediatric Suicide Need Immediate Strengthening
Strengthened warnings about the risk of suicide ideation and attempts among children taking antidepressant medications should be communicated to physicians and consumers as soon as possible, a joint FDA advisory committee told the agency Feb. 2